Medroxyprogesterone Acetate With or Without Entinostat Before Surgery in Treating Patients With Endometrioid Endometrial Cancer

NCT03018249 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

50

Enrollment

NIH

Sponsor class

Conditions

FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma
FIGO Grade 3 Endometrial Endometrioid Adenocarcinoma

Interventions

DRUG: Entinostat
PROCEDURE: Hysterectomy
OTHER: Laboratory Biomarker Analysis
DRUG: Medroxyprogesterone Acetate

Sponsor

National Cancer Institute (NCI)

Collaborators

[object Object]